A prediction rule to identify low-risk patients with community-acquired pneumonia.

A BSTRACT Background There is considerable variability in rates of hospitalization of patients with communityacquired pneumonia, in part because of physicians’ uncertainty in assessing the severity of illness at presentation. Methods From our analysis of data on 14,199 adult inpatients with community-acquired pneumonia, we derived a prediction rule that stratifies patients into five classes with respect to the risk of death within 30 days. The rule was validated with 1991 data on 38,039 inpatients and with data on 2287 inpatients and outpatients in the Pneumonia Patient Outcomes Research Team (PORT) cohort study. The prediction rule assigns points based on age and the presence of coexisting disease, abnormal physical findings (such as a respiratory rate of 30 per minute or a temperature of 40°C), and abnormal laboratory findings (such as a pH 7.35, a blood urea nitrogen concentration 30 mg per deciliter [11 mmol per liter] or a sodium concentration 130 mmol per liter) at presentation. Results There were no significant differences in mortality in each of the five risk classes among the three cohorts. Mortality ranged from 0.1 to 0.4 percent for class I patients (P 0.22), from 0.6 to 0.7 percent for class II (P 0.67), and from 0.9 to 2.8 percent for class III (P 0.12). Among the 1575 patients in the three lowest risk classes in the Pneumonia PORT cohort, there were only seven deaths, of which only four were pneumonia-related. The risk class was significantly associated with the risk of subsequent hospitalization among those treated as outpatients and with the use of intensive care and the number of days in the hospital among inpatients. Conclusions The prediction rule we describe accurately identifies the patients with communityacquired pneumonia who are at low risk for death and other adverse outcomes. This prediction rule may help physicians make more rational decisions about hospitalization for patients with pneumonia. (N Engl J Med 1997;336:243-50.)

[1]  H. Dorn,et al.  Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death. Vol. I , 1950 .

[2]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.

[3]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[4]  E. Keeler,et al.  Primer on certain elements of medical decision making. , 1975, The New England journal of medicine.

[5]  N. Breslow,et al.  Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. , 1981 .

[6]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[7]  P. Dans,et al.  Management of pneumonia in the prospective payment era. A need for more clinician and support service interaction. , 1984, Archives of internal medicine.

[8]  R. Garibaldi,et al.  Epidemiology of community-acquired respiratory tract infections in adults , 1985, The American Journal of Medicine.

[9]  L. Hyde,et al.  MEDISGRPS: a clinically based approach to classifying hospital patients at admission. , 1985, Inquiry : a journal of medical care organization, provision and financing.

[10]  Community-acquired lower respiratory tract infections. Prevention and cost-control strategies. , 1985, The American journal of medicine.

[11]  H. Sox,et al.  Clinical prediction rules. Applications and methodological standards. , 1985, The New England journal of medicine.

[12]  J. Freeman,et al.  ARE HOSPITAL SERVICES RATIONED IN NEW HAVEN OR OVER-UTILISED IN BOSTON? , 1987, The Lancet.

[13]  D Draper,et al.  Predicting hospital-associated mortality for Medicare patients. A method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure. , 1988, JAMA.

[14]  L I Iezzoni,et al.  A clinical assessment of MedisGroups. , 1988, JAMA.

[15]  D Draper,et al.  Interpreting hospital mortality data. The role of clinical risk adjustment. , 1988, JAMA.

[16]  John E. Wennberg,et al.  Using diagnosis-related groups for studying variations in hospital admissions , 1988, Health care financing review.

[17]  L. McMahon,et al.  Variation in Hospital Admissions Among Small Areas: A Comparison of Maine and Michigan , 1989, Medical care.

[18]  T. Marrie,et al.  Community-acquired pneumonia requiring hospitalization: 5-year prospective study. , 1989, Reviews of infectious diseases.

[19]  M. Fine,et al.  Prognosis of patients hospitalized with community-acquired pneumonia. , 1990, The American journal of medicine.

[20]  D Draper,et al.  Changes in sickness at admission following the introduction of the prospective payment system. , 1990, JAMA.

[21]  M. Fine,et al.  Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. , 1990, The American journal of medicine.

[22]  M. Leinonen,et al.  Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. , 1990, The European respiratory journal.

[23]  Jerome J. Schentag,et al.  Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. , 1991, The American journal of medicine.

[24]  M. Fisch,et al.  Predicting death in patients hospitalized for community-acquired pneumonia. , 1991, Annals of internal medicine.

[25]  N. J. Ehrenkranz,et al.  Intervention to Discontinue Parenteral Antimicrobial Therapy in Patients Hospitalized with Pulmonary Infections: Effect on Shortening Patient Stay , 1992, Infection Control & Hospital Epidemiology.

[26]  W. Osmun.  Effects of a medical team coordinator on length of hospital stay. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[27]  E. Ibrahim,et al.  Community acquired acute bacterial and atypical pneumonia in Saudi Arabia. , 1992, Thorax.

[28]  M. Fine,et al.  Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. , 1993, The American journal of medicine.

[29]  H. Selker.  Criteria for adoption in practice of medical practice guidelines. , 1993, The American journal of cardiology.

[30]  A. Ellrodt,et al.  Identification of low-risk hospitalized patients with pneumonia. Implications for early conversion to oral antimicrobial therapy. , 1994, Chest.

[31]  D. Collet.  Modelling Survival Data in Medical Research , 2004 .

[32]  Medicare and Medicaid statistical supplement. , 1994, Health care financing review. Statistical supplement.

[33]  E. Scott.  Modelling Survival Data in Medical Research , 1995 .

[34]  J. Wyatt,et al.  Commentary: Prognostic models: clinically useful or quickly forgotten? , 1995 .

[35]  J. Ramirez,et al.  Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. , 1995, Archives of internal medicine.

[36]  A. Detsky,et al.  Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. , 1996, Archives of internal medicine.

[37]  J H Wasson,et al.  Clinical Prediction Rules: Have They Come of Age? , 1996 .

[38]  M. Fine,et al.  Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. , 1996, JAMA.

[39]  Sheldon P Stone,et al.  Community-acquired pneumonia , 1998, The Lancet.

[40]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.